查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1873983

過敏治療市場

Allergy Treatment Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

預計過敏治療市場將從2024年的217.7億美元成長到2031年的335億美元，2031年至2031年期間的年複合成長率（CAGR）為7.8%。研發投入的增加預計將成為該市場的重要趨勢。

過敏治療市場分析

旨在研發創新抗過敏藥物的研發投入增加，預計在不久的將來成為一大趨勢。儘管目前市面上已有多種抗過敏藥物，但許多呼吸道過敏和氣喘患者僅靠對症治療仍無法有效控制病情或獲得充分療效。例如，某些呼吸道過敏可導致氣喘的發生。因此，領先的製藥公司正在啟動針對過敏症的臨床試驗項目，例如HAL Allergy BV公司針對呼吸道過敏症推出的「過敏原免疫療法」。預計研發活動的增加將催生新型抗過敏藥物，並在2021年至2031年間顯著推動市場成長。

過敏治療市場概覽

根據氣喘過敏診所報道，世界過敏組織（WAO）的最新研究結果表明，14%的人患有氣喘，20%的人患有過敏性鼻炎（AR），後者是由IgE介導的鼻粘膜發炎引起的。目前，印度約有20-30%的人口受到一種或多種過敏性疾病的影響，預計未來幾年這一比例將持續上升。因此，過敏症發病率的不斷成長可能會在未來十年推動抗過敏藥物的需求。

戰略洞察

過敏治療市場的促進因素與機遇

過敏症發生率上升推高了對過敏藥物的需求

根據美國兒科學會的報告，花粉症（過敏性鼻炎）是最常見的過敏類型，導致巨額治療費用。過敏治療的直接和間接費用每年超過70億美元。有效的過敏治療取決於病史、過敏測試結果和症狀的嚴重程度。免疫療法是某些過敏患者的可行治療選擇，主要有兩種形式：脫敏針和舌下免疫療法（SLIT）。脫敏針是指隨著時間的推移，逐漸增加過敏原的劑量，幫助患者逐漸降低對這些過敏原的敏感度。這種針劑對花粉、寵物、灰塵、蜜蜂和其他螫刺性昆蟲過敏的人以及氣喘患者都有效。因此，過敏病例的不斷增加是全球過敏治療市場的主要驅動力。

新藥獲批帶來極具吸引力的市場機會

新藥獲準用於治療過敏症，為過敏症治療市場帶來了豐厚的機會。 2020年6月，卡迪拉製藥有限公司（Cadila Pharmaceuticals Limited）推出了「比拉斯汀糖漿（30毫升）」和20毫克規格的比拉斯汀片。此外，2022年3月，佩里戈公司（Perrigo Company plc）的「內舒拿® 24小時抗過敏藥（糠酸莫米鬆一水合物50微克）」獲得了美國食品藥品監督管理局（FDA）的最終批准，可以作為非處方藥（OTC）使用，這標誌著該公司首個處方藥。

過敏治療市場細分分析

過敏治療市場分析源自於基於類型、病因、疾病類型、類別和最終用戶的關鍵細分市場。

  • 市場按過敏類型分為眼睛過敏、鼻炎、氣喘、皮膚過敏、食物過敏和其他，其中鼻炎在 2023 年佔據最大的市場佔有率。
  • 按治療類型分類，市場分為抗過敏藥物和免疫療法，其中抗過敏藥物在 2023 年佔據最大的市場佔有率。

過敏治療市場的地理分析

過敏治療市場報告的地理範圍分為五個地區：北美、亞太地區、歐洲、中東和非洲以及南美和中美洲。

北美市場佔據主導地位，其中美國在過敏治療市場佔最大佔有率。該地區擁有眾多領先製造商，以及他們研發的具有高效藥理特性的創新抗過敏藥物，這些因素共同促成了其市場主導地位。預計未來幾年，亞太地區將實現最高的複合年成長率。

過敏治療市場報告範圍

過敏治療市場的最新發展

過敏治療市場評估是基於從一手和二手研究中收集的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。過敏治療市場的主要發展趨勢包括：

  • 2024年2月，諾華公司宣布其新上市產品「Xolair（奧馬哈珠單抗）」獲得美國食品藥物管理局（FDA）批准。本產品旨在減少成人和1歲及以上兒童IgE介導的食物過敏患者因意外接觸某些食物而引起的過敏反應，包括過敏性休克。 （圖片來源：諾華公司網站，2024年2月）

過敏治療市場報告的覆蓋範圍和交付成果

這份題為《過敏治療市場規模及預測（2021-2031）》的報告對市場進行了全面分析，涵蓋以下領域：

  • 過敏治療市場規模及預測，涵蓋全球、區域和國家層面的所有關鍵細分市場。
  • 過敏治療市場的發展趨勢以及市場動態，例如促進因素、限制因素和關鍵機會。
  • 深入的PEST/波特五力模型與SWOT分析
  • 對過敏治療市場進行分析，涵蓋關鍵趨勢、全球和區域框架、主要參與者、法規以及近期市場發展動態。
  • 過敏治療市場的產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展動態
  • 主要公司的詳細概況

目錄

第1章：引言

第2章：過敏治療市場及主要結論

第3章：研究方法

  • 覆蓋範圍
  • 二手研究
  • 初步研究

第4章：全球過敏治療市場及市場概況

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 歐洲 PEST 分析
    • 亞太地區PEST分析
    • MEA PEST 分析
    • 騙局害蟲分析
  • 專家意見
  • 按地區分類的公司列表

第5章：過敏治療市場及關鍵產業動態

  • 主要市場促進因素
    • 免疫療法在過敏治療的應用日益廣泛
    • 食物過敏治療進展
  • 主要市場限制因素
    • 缺乏對過敏治療的認知
  • 主要市場機遇
    • 與過敏相關的研究項目和計劃數量不斷增加
  • 未來趨勢
    • 開發和批准用於治療過敏和氣喘的創新藥物，例如生物製劑
  • 影響分析

第6章：過敏治療市場及全球分析

  • 全球過敏治療市場收入預測與分析
  • 全球過敏治療市場（依地域分類）－預測與分析
  • 關鍵參與者的市場定位

第7章：過敏治療市場分析及依過敏類型分類

  • 概述
  • 2020 年和 2031 年按過敏類型分類的過敏治療市場（%）
  • 眼睛過敏
  • 鼻炎
  • 氣喘
  • 皮膚過敏
  • 食物過敏
  • 其他過敏

第8章：過敏治療市場分析及依治療方式分類

  • 概述
  • 2020 年及 2031 年過敏治療市場（依治療方法分類）
  • 抗過敏藥物
  • 免疫療法

第9章：過敏治療市場及地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太
      • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第10章：新冠肺炎疫情對全球過敏治療市場的影響

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 南美洲和中美洲

第11章：過敏治療市場及產業概況

  • 概述
  • 市場中各公司採取的成長策略（%）
  • 有機發展
    • 概述
  • 無機物發展
    • 概述

第12章：公司簡介

  • Johnson and Johnson Services, Inc.
  • Sanofi
  • AbbVie Inc.
  • Pfizer Inc.
  • LETI Pharma
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Stallergenes Greer
  • GlaxoSmithKline plc.
  • Dermapharm Holding

第13章：附錄

第14章：附錄

簡介目錄
Product Code: TIPRE00004584

The allergy treatment market is anticipated to grow from US$ 21.77 billion in 2024 to US$ 33.5 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.8% during the period from 2031 to 2031. Increased research and development (R&D) efforts are expected to be a significant trend in this market.

Analysis of the Allergy Treatment Market

Increased R&D initiatives aimed at creating innovative allergy medications are likely to emerge as a prominent trend in the near future. Although there are numerous allergy medications available, many patients suffering from respiratory allergies and asthma still experience inadequate control or insufficient treatment through symptomatic therapies. For instance, certain respiratory allergies can lead to asthma development. Consequently, leading manufacturers are initiating clinical trial programs focused on allergies, such as HAL Allergy B.V.'s "Allergen Immunotherapies" for respiratory allergies. Thus, the rise in R&D activities is expected to lead to the creation of new anti-allergic medications, significantly contributing to market growth from 2021 to 2031.

Overview of the Allergy Treatment Market

As reported by the Asthma Allergy Clinic, new findings from the World Allergy Organization (WAO) indicate that 14% of individuals have asthma, while 20% suffer from allergic rhinitis (AR), which causes IgE-mediated inflammation of the nasal mucosa. Currently, approximately 20-30% of the population in India is affected by one or more allergic conditions, with this prevalence expected to increase in the coming years. Therefore, the growing incidence of allergies is likely to drive demand for anti-allergic medications over the next decade.

Strategic Insights

Drivers and Opportunities in the Allergy Treatment Market

Increasing Allergy Incidence Boosts Demand for Anti-Allergic Medications

According to a report from the American Academy of Pediatrics, Hay Fever (allergic rhinitis) is the most prevalent type of allergy, contributing to significant treatment costs. The direct and indirect expenses for allergy treatment exceed US$7 billion annually. Effective allergy treatment is based on medical history, allergy test results, and the severity of symptoms. Immunotherapy is a viable treatment option for certain allergy sufferers, with two common forms: allergy shots and sublingual immunotherapy (SLIT). Allergy shots involve administering increasing doses of allergens over time, helping individuals become progressively less sensitive to those allergens. These shots can be effective for people allergic to pollen, pets, dust, bees, and other stinging insects, as well as for asthma sufferers. Thus, the rising number of allergy cases is a major driver for the global allergy treatment market.

New Drug Approvals Present Attractive Market Opportunities

The approval of new drugs for allergy treatment offers lucrative opportunities within the allergy treatment market. In June 2020, Cadila Pharmaceuticals Limited launched "Bilastine Syrup (30ml)" and Bilastine Tablets of 20mg strength. Furthermore, in March 2022, Perrigo Company plc received final approval from the USFDA for the over-the-counter (OTC) use of "Nasonex(R) 24HR Allergy (mometasone furoate monohydrate 50mcg)", marking the company's first Rx-to-OTC switch for "Nasonex" to enter the OTC market.

Segmentation Analysis of the Allergy Treatment Market

The allergy treatment market analysis is derived from key segments based on type, cause, disorder type, category, and end user.

  • The market is segmented by allergy type into eye allergies, rhinitis, asthma, skin allergies, food allergies, and others, with the rhinitis segment holding the largest market share in 2023.
  • By treatment type, the market is divided into anti-allergy drugs and immunotherapies, with the anti-allergy drugs segment capturing the largest market share in 2023.

Geographical Analysis of the Allergy Treatment Market

The geographical scope of the Allergy Treatment market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America leads the market, with the US holding the largest share of the allergy treatment market. The presence of leading manufacturers in the region and their innovative anti-allergic drugs with effective pharmacological properties contribute to this dominance. The Asia Pacific region is expected to experience the highest CAGR in the coming years.

Scope of the Allergy Treatment Market Report

Recent Developments in the Allergy Treatment Market

The Allergy Treatment market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Notable developments in the Allergy Treatment market include:

  • In February 2024, Novartis announced the US Food and Drug Administration (USFDA) approval of "Xolair (omalizumab)", a newly launched product designed to reduce allergic reactions, including anaphylaxis due to accidental exposure to certain foods in adults and pediatric patients aged 1 year and older with IgE-mediated food allergies. (Source: Novartis, Company Website, February 2024)

Coverage and Deliverables of the Allergy Treatment Market Report

The report titled "Allergy Treatment Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Allergy treatment market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Trends in the Allergy Treatment market along with market dynamics such as drivers, restraints, and key opportunities
  • In-depth PEST/Porter's Five Forces and SWOT analysis
  • Analysis of the Allergy Treatment market covering key trends, global and regional frameworks, major players, regulations, and recent market developments
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments in the Allergy Treatment market
  • Detailed profiles of key companies

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Allergy Treatment Market and By Allergy Type
    • 1.3.2 Allergy Treatment Market and By Treatment
    • 1.3.3 Allergy Treatment Market and By Geography

2. Allergy Treatment Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Allergy Treatment Marketand Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 APAC PEST Analysis
    • 4.2.4 MEA PEST Analysis
    • 4.2.5 SCAM PEST Analysis
  • 4.3 Expert Opinion
  • 4.4 List of Companies, by Region

5. Allergy Treatment Market and Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Adoption of Immunotherapy in Allergy Treatment
    • 5.1.2 Developments in Food Allergy Treatments
  • 5.2 Key Market Restraints
    • 5.2.1 Lack of Awareness About Allergy Treatments
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Number of Allergy-Related Research Projects and Programs
  • 5.4 Future Trends
    • 5.4.1 Development and Approvals of Innovative Medicines such as Biologics for Treating Allergies and Asthma
  • 5.5 Impact Analysis

6. Allergy Treatment Market and Global Analysis

  • 6.1 Global Allergy Treatment Marker Revenue Forecast and Analysis
  • 6.2 Global Allergy Treatment Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Allergy Treatment Market Analysisand by Allergy Type

  • 7.1 Overview
  • 7.2 Allergy Treatment Market, by Allergy Type 2020 and 2031 (%)
  • 7.1 Eye Allergy
    • 7.1.1 Overview
    • 7.1.2 Eye Allergy: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.2 Rhinitis
    • 7.2.1 Overview
    • 7.2.2 Rhinitis: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.3 Asthma
    • 7.3.1 Overview
    • 7.3.2 Asthma: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.4 Skin Allergy
    • 7.4.1 Overview
    • 7.4.2 Skin Allergy: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.5 Food Allergies
    • 7.5.1 Overview
    • 7.5.2 Food Allergies: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.6 Other Allergies
    • 7.6.1 Overview
    • 7.6.2 Other Allergies: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)

8. Allergy Treatment Market Analysisand by Treatment

  • 8.1 Overview
  • 8.2 Allergy Treatment Market, by Treatment 2020 and 2031 (%)
  • 8.3 Anti-Allergy Drugs
    • 8.3.1 Overview
    • 8.3.2 Anti-Allergy Drugs: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.3.3 Antihistamines
      • 8.3.3.1 Overview
      • 8.3.3.2 Antihistamines: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.3.4 Corticosteroids
      • 8.3.4.1 Overview
      • 8.3.4.2 Corticosteroids: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.3.5 Decongestants
      • 8.3.5.1 Overview
      • 8.3.5.2 Decongestants: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.3.6 Other Drug
      • 8.3.6.1 Overview
      • 8.3.6.2 Other Drug: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 8.4 Immunotherapy
    • 8.4.1 Overview
    • 8.4.2 Immunotherapy: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.4.3 Sub-cutaneous Immunotherapy (SCIT)
      • 8.4.3.1 Overview
      • 8.4.3.2 Sub-cutaneous Immunotherapy (SCIT): Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.4.4 Sub-Lingual Immunotherapy (SLIT)
      • 8.4.4.1 Overview
      • 8.4.4.2 Sub-Lingual Immunotherapy (SLIT): Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)

9. Allergy Treatment Market and Geographical Analysis

  • 9.1 North America: Allergy Treatment Market
    • 9.1.1 Overview
    • 9.1.2 North America: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
    • 9.1.3 North America: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
    • 9.1.4 North America: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
      • 9.1.4.1 North America: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
      • 9.1.4.2 North America: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.1.5 North America: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.1.6 US: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.6.1 US: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.6.2 US: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.1.6.3 US: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.1.6.3.1 US: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.1.6.3.2 US: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.1.7 Canada: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.7.1 Canada: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.7.2 Canada: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.1.7.3 Canada: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.1.7.3.1 Canada: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.1.7.3.2 Canada: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.1.8 Mexico: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.8.1 Mexico: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.8.2 Mexico: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.1.8.3 Mexico: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.1.8.3.1 Mexico: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.1.8.3.2 Mexico: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
  • 9.2 Europe: Allergy Treatment Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
    • 9.2.3 Europe: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
    • 9.2.4 Europe: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
      • 9.2.4.1 Europe: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
      • 9.2.4.2 Europe: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.5 Europe: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.2.6 Germany: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.6.1 Germany: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.6.2 Germany: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.6.3 Germany: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.6.3.1 Germany: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.6.3.2 Germany: Allergy Treatment Market, by Immunotherapy 2024 and 2031 (USD Million)
    • 9.2.7 UK: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.7.1 UK: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.7.2 UK: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.7.3 UK: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.7.3.1 UK: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.7.3.2 UK: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.8 France: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.8.1 France: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.8.2 France: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.8.3 France: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.8.3.1 France: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.8.3.2 France: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.9 Italy: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.9.1 Italy: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.9.2 Italy: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.9.3 Italy: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.9.3.1 Italy: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.9.3.2 Italy: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.10 Spain: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.10.1 Spain: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.10.2 Spain: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.10.3 Spain: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.10.3.1 Spain: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.10.3.2 Spain: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.11 Rest of Europe: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.11.1 Rest of Europe: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.11.2 Rest of Europe: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.11.3 Rest of Europe: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.11.3.1 Rest of Europe: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.11.3.2 Rest of Europe: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
  • 9.3 Asia-Pacific: Allergy Treatment Market
    • 9.3.1 Overview
    • 9.3.2 Asia-Pacific: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
    • 9.3.3 Asia-Pacific: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
    • 9.3.4 Asia-Pacific: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
      • 9.3.4.1 Asia-Pacific: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
      • 9.3.4.2 Asia-Pacific ca: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.5 Asia-Pacific: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.3.6 China: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.6.1 China: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.6.2 China: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.6.3 China: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.6.3.1 China: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.6.3.2 China: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.7 Japan: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.7.1 Japan: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.7.2 Japan: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.7.3 Japan: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.7.3.1 Japan: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.7.3.2 Japan: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.8 India: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.8.1 India: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.8.2 India: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.8.3 India: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.8.3.1 India: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.8.3.2 India: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.9 Australia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.9.1 Australia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.9.2 Australia: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.9.3 Australia: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.9.3.1 Australia: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.9.3.2 Australia: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.10 South Korea: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.10.1 South Korea: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.10.2 South Korea: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.10.3 South Korea: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.10.3.1 South Korea: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.10.3.2 South Korea: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.11 Rest of Asia-Pacific: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.11.1 Rest of Asia-Pacific: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.11.2 Rest of Asia-Pacific: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.11.3 Rest of Asia-Pacific: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.11.3.1 Rest of Asia-Pacific: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.11.3.2 Rest of Asia-Pacific: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
  • 9.4 Middle East and Africa: Allergy Treatment Market
    • 9.4.1 Overview
    • 9.4.2 Middle East and Africa: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
    • 9.4.3 Middle East and Africa: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
    • 9.4.4 Middle East and Africa: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
      • 9.4.4.1 Middle East and Africa: Allergy Treatment, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
      • 9.4.4.2 Middle East and Africa: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.4.5 Middle East and Africa: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.4.6 Saudi Arabia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.6.1 Saudi Arabia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.6.2 Saudi Arabia: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.4.6.3 Saudi Arabia: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.4.6.3.1 Saudi Arabia: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.4.6.3.2 Saudi Arabia: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.4.7 South Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.7.1 South Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.7.2 South Africa: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.4.7.3 South Africa: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.4.7.3.1 South Africa: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.4.7.3.2 South Africa: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.4.8 UAE: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.8.1 UAE: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.8.2 UAE: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.4.8.3 UAE: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.4.8.3.1 UAE: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.4.8.3.2 UAE: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.4.9 Rest of Middle East and Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.9.1 Rest of Middle East and Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.9.2 Rest of Middle East and Africa: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.4.9.3 Rest of Middle East and Africa: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.4.9.3.1 Rest of Middle East and Africa: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.4.9.3.2 Rest of Middle East and Africa: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
  • 9.5 South and Central America: Allergy Treatment Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
    • 9.5.3 South and Central America Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
    • 9.5.4 South and Central America Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
      • 9.5.4.1 South and Central America: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.4.2 South and Central America: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.4.3 South and Central America: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.5.5 Brazil: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.5.1 Brazil: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.5.2 Brazil Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.5.3 Brazil Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
        • 9.5.5.3.1 Brazil: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
        • 9.5.5.3.2 Brazil: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)
    • 9.5.6 Argentina: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.1 Argentina: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.2 Argentina Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.3 Argentina Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.4 Argentina: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.5 Argentina: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)
    • 9.5.7 Rest of South and Central America: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.7.1 Rest of South and Central America: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.7.2 Rest of South and Central America Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.7.3 Rest of South and Central America Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
        • 9.5.7.3.1 Rest of South and Central America: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
        • 9.5.7.3.2 Rest of South and Central America: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)

10. Impact of COVID-19 Pandemic on Global Allergy Treatment Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Allergy Treatment Marketand Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Johnson and Johnson Services, Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sanofi
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 AbbVie Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Pfizer Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 LETI Pharma
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 ALK-Abello A/S
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Allergy Therapeutics
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Stallergenes Greer
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 GlaxoSmithKline plc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Dermapharm Holding
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Glossary of Terms